港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

瑞博生物-B

82.100

+24.13041.62%

成交量：1,415.18万

成交额：10.57亿

市值：136.29亿

市盈率：-44.26

高：87.000

开：75.000

低：65.900

收：57.970

52周最高：87.000

52周最低：65.900

股本：1.66亿

香港流通股本：1.66亿

量比：- -

换手率：8.53%

股息：- -

股息率：- -

每股收益(LYR):-1.855

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):-44.26

市销率: - -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

农银国际作为整体协调人协助瑞博生物成功在香港联交所上市

磐霖资本迎来收获季：连投6轮的明星企业上市了

行业快讯 | 一周药闻速揽：小核酸药物领军企业瑞博生物正式在港交所上市

等了19年！中国“小核酸第一股”上市，科学家创业有多难？

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/06938"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06938","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06938\",,,,,undefined,":{"symbol":"06938","market":"HK","secType":"STK","nameCN":"瑞博生物-B","latestPrice":82.1,"timestamp":1767946113584,"preClose":57.97,"halted":0,"volume":14151773,"delay":0,"floatShares":166000000,"shares":166000000,"eps":-1.855,"marketStatus":"休市中","change":24.13,"latestTime":"01-09 16:08:33","open":75,"high":87,"low":65.9,"amount":1056891078,"amplitude":0.363981,"askPrice":83.6,"askSize":200,"bidPrice":82.1,"bidSize":10000,"shortable":0,"etf":0,"ttmEps":-1.502,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":7,"adr":0,"listingDate":1767888000000,"exchange":"SEHK","adjPreClose":57.97,"openAndCloseTimeList":[[1767922200000,1767931200000],[1767934800000,1767945600000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06938\",,,,,undefined,":{"symbol":"06938","floatShares":166000000,"roa":"--","roe":"--","lyrEps":-1.855,"shares":166000000,"dividePrice":0,"high":87,"amplitude":0.363981,"preClose":57.97,"low":65.9,"week52Low":65.9,"pbRate":"--","week52High":87,"institutionHeld":0,"latestPrice":82.1,"committee":0.960784,"eps":-1.855,"divideRate":0,"volume":14151773,"delay":0,"ttmEps":-1.502,"open":75,"prevYearClose":57.97,"prevWeekClose":57.97,"prevMonthClose":57.97,"prevQuarterClose":57.97,"fiveDayClose":57.97,"twentyDayClose":57.97,"sixtyDayClose":57.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06938\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06938\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06938\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06938\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602321745","title":"农银国际作为整体协调人协助瑞博生物成功在香港联交所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2602321745","media":"农银国际","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602321745?lang=zh_cn&edition=fundamental","pubTime":"2026-01-11 10:25","pubTimestamp":1768098352,"startTime":"0","endTime":"0","summary":"2026年1月9日，农银国际作为整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人协助苏州瑞博生物技术股份有限公司在香港交易所主板成功上市。瑞博生物此次发行价格为每H股57.97港元，募集资金约18亿港元。农银国际作为整体协调人，凭借自身对生物制药行业及跨境资本的深度理解，积极沟通高质量投资人，为公司成功上市保驾护航。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260111104124a70c7475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260111104124a70c7475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06938"],"gpt_icon":1},{"id":"2602589048","title":"磐霖资本迎来收获季：连投6轮的明星企业上市了","url":"https://stock-news.laohu8.com/highlight/detail?id=2602589048","media":"投中网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602589048?lang=zh_cn&edition=fundamental","pubTime":"2026-01-10 15:09","pubTimestamp":1768028983,"startTime":"0","endTime":"0","summary":"彼时的磐霖资本正处于从PE向VC转型的当口，尽管此前，磐霖资本经投出了康泰生物、凯普生物等明星企业并成功在A股上市。没有过多犹豫，磐霖资本毅然领投6000万。十年来，通过这六轮投资，磐霖资本已经成为瑞博生物投资轮次最多的机构，同时也是投资金额最大的两家机构之一，这完美诠释了一级市场提倡的“长期陪伴、价值投资”的理念。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110151113a70a1d1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110151113a70a1d1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06938"],"gpt_icon":1},{"id":"2602856755","title":"行业快讯 | 一周药闻速揽：小核酸药物领军企业瑞博生物正式在港交所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2602856755","media":"CBP药谷","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602856755?lang=zh_cn&edition=fundamental","pubTime":"2026-01-10 10:02","pubTimestamp":1768010528,"startTime":"0","endTime":"0","summary":"关注行业最新动向01.03-01.09一周药政速揽1月7日，国家药监局网站发布关于进一步优化临床急需境外已上市药品审评审批有关事项的公告。行业新闻动态热点NEWS瑞博生物正式在港交所上市1月9日，小核酸药物领军企业瑞博生物正式在港交所首发上市。与此同时，公司还与一家美国纳斯达克上市企业达成小核酸药物领域的国际战略合作协议，合作规模达上亿美元，标志着安龙生物在国际BD合作方面取得重要突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110120802a4b2b308&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110120802a4b2b308&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06938"],"gpt_icon":0},{"id":"2602712377","title":"等了19年！中国“小核酸第一股”上市，科学家创业有多难？","url":"https://stock-news.laohu8.com/highlight/detail?id=2602712377","media":"财能圈","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602712377?lang=zh_cn&edition=fundamental","pubTime":"2026-01-09 21:44","pubTimestamp":1767966284,"startTime":"0","endTime":"0","summary":"长达十九年的漫长等待，换来港交所一记钟声——中国小核酸药物终于迎来首个上市公司，但这漫长的上市路，折射出中国原创新药研发的残酷现实。瑞博生物今日在港交所正式挂牌，成为中国小核酸药物领域第一股。作为中国小核酸药物第一股，其估值逻辑需要经受资本市场严苛审视。开盘29%的涨幅反映了市场对中国小核酸第一股的短期热情，但这种热情能够持续多久仍是未知数。等待了十九年，中国小核酸药物终于迎来了第一个上市公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109235930a4b10d7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109235930a4b10d7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06938"],"gpt_icon":1}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/06938\",params:#limit:6,delay:false,,,undefined,":[]}}